PODCAST · business
Small Stocks, Big Money
by RedChip Companies
RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.
Episodes
-
Autonomous Navigation in GPS-Denied Environments | CEO Ben Williams on Exyn Technologies (EXYN)
Ben Williams, CEO and COO of Exyn Technologies (Nasdaq: EXYN), explains how the company's ExynAI platform solves one of robotics' hardest problems: navigating and mapping in places where GPS simply doesn't work.Exyn is an autonomous robotics and geospatial intelligence company built on its...
-
8 Products, One Ore Body, $560/Ton Margin: CEO Mark Smith on NioCorp's Updated Feasibility Study
CEO Mark Smith joins RedChip to break down NioCorp's (Nasdaq: NB) newly updated Elk Creek feasibility study and the company's expanding role in U.S. critical minerals supply.NioCorp Developments is advancing the Elk Creek Critical Minerals Project in Nebraska, a domestic source of niobium,...
-
Tokenizing Wall Street: David Wachsman on Hawkeye Digital (OTC: HWKE)
Visit RedChip.com to learn David Wachsman, President of Hawkeye Digital, Inc. (OTC: HWKE), joins RedChip to break down a new platform built to bridge Wall Street and the digital asset industry.Hawkeye is building an integrated merchant banking and private equity platform focused on the...
-
RedChip Highlights Virax Biolabs Group (NASDAQ: VRAX) & TransCode Therapeutics (NASDAQ: RNAZ)
This week's episode of Small Stocks Big Money features exclusive interviews with senior executives from Virax Biolabs Group (NASDAQ: VRAX) & TransCode Therapeutics (NASDAQ: RNAZ)Explore the latest insights and updates in the world of small-cap stocks.Visit RedChip.com to learn more.
-
RedChip Highlights Nord Precious Metals Mining Inc.(OTCQB: NPMMF) &OBOOK Holdings Inc.(NASDAQ: OWLS)
This week's episode of Small Stocks Big Money features exclusive interviews with senior executives from Nord Precious Metals Mining Inc. (OTCQB: NPMMF) & OBOOK Holdings Inc. (NASDAQ: OWLS)Explore the latest insights and updates in the world of small-cap stocks.Visit RedChip.com to learn more.
-
RedChip Highlights Venu Holding Corporation (NYSE American: VENU) & Proactive Sustainable Bonds
This week's episode of Small Stocks Big Money features exclusive interviews with senior executives from Venu Holding Corporation (NYSE American: VENU) & Proactive Sustainable BondsExplore the latest insights and updates in the world of small-cap stocks.Visit RedChip.com to learn more.
-
RedChip Highlights Bimergen Energy(NYSE American: BESS) & Alliance Entertainment (NASDAQ: AENT)
This week's episode of Small Stocks Big Money features exclusive interviews with senior executives from Bimergen Energy (NYSE American: BESS) & Alliance Entertainment (NASDAQ: AENT)Explore the latest insights and updates in the world of small-cap stocks.Visit RedChip.com to learn more.
-
Alliance Entertainment (Nasdaq: AENT): Building the Authentication Layer for Vinyl Collectors
Alliance Entertainment (Nasdaq: AENT) SVP of Sales & Marketing Jeffrey Smith joins RedChip to break down Alliance Authentic™, Alliance's new certified vinyl collectibles platform.Alliance sits structurally between the pressing plant and the consumer, certifying every record as uncirculated before...
-
CEO Frank Basa on Nord Precious Metals' (OTCQB: NPMMF) 29 Veins Inside of One Historic Silver Camp
CEO Frank Basa joins RedChip to break down Nord Precious Metals' (TSXV: NTH | OTCQB: NPMMF) two-track strategy in one of Canada's richest historic silver districts.Nord controls the Castle Mine project in Ontario's historic cobalt-silver camp, where initial results came in at over 8,000 grams per...
-
Alliance Entertainment (Nasdaq: AENT): $1B Revenue, 33% Movie Growth & the Collectibles Shift
Ken Glaser, Senior Vice President of Sales at Alliance Entertainment (Nasdaq: AENT), breaks down how the company's independent retail channel is generating early market intelligence — and why that advantage matters for the broader $1B+ platform.Alliance Entertainment is one of the largest...
-
CEO Paul Mann on ASP Isotopes (Nasdaq: ASPI): 4 Facilities, $38B Market & Western Supply Security
Paul Mann, CEO of ASP Isotopes (Nasdaq: ASPI), joins us to break down the company's shift from isotope developer to commercial-scale critical materials supplier.ASP Isotopes uses its proprietary Aerodynamic Separation Process and Quantum Enrichment technology to produce isotopes and critical…
more -
Co-CEO Bob Brilon on Bimergen Energy's (NYSE: BESS) 23-Project Energy Arbitrage Pipeline
Co-CEO Bob Brilon joins RedChip to discuss Bimergen Energy's (NYSE American: BESS) strategy for building, financing, and operating utility-scale and distributed battery energy storage systems across the fastest-growing power markets in the United States.Bimergen develops battery farms —...
-
CEO Lavell Malloy on Brag House's (Nasdaq: TBH) Blockchain Sports Platform & Athlete Tokenization
CEO Lavell Juan Malloy II joins RedChip to discuss Brag House (Nasdaq: TBH), a media-tech platform building at the intersection of Gen Z fandom, blockchain infrastructure, and global athlete IP.Brag House is built on the belief that culture is capital. With its shareholder-approved merger with...
-
CEO James Foster on Virax Biolabs' (VRAX) Long COVID Diagnostic & US Market Entry
In our investor-focused interview, James Foster, CEO of Virax Biolabs Group Ltd. (Nasdaq: VRAX), breaks down how the company is developing a potential first-in-category immune function diagnostic targeting post-acute infection syndromes (PAIS) — a large, underserved category affecting an…
more -
Jeremy Schwartz CIO of WisdomTree ($WT): $165B AUM, Mega Trends & Why WT Is a Secular Growth Stock
In our investor-focused interview, Jeremy Schwartz, Global CIO of WisdomTree (NYSE: WT), breaks down how the firm grew from 20 funds to a $165B global asset manager delivering 50% annual earnings growth — and why he believes WT trades at a significant discount to its true growth profile.Jeremy...
-
First Phosphate (FRSPF) CEO on Agnico's $94M Bet Leaves Only 2 Independents Standing
In our exclusive interview, John Passalacqua, CEO & Director of First Phosphate ($FRSPF | CSE: PHOS), discusses the seismic $94 million all-cash acquisition by Avenir Minerals (Agnico Mines subsidiary) and explains what it signals for the LFP battery supply chain and for First Phosphate.Key…
more -
Anixa Biosciences (ANIX): CEO on Breast Cancer Vaccine, Phase 2 Catalyst & Ovarian Cancer CAR-T Data
Anixa Biosciences (Nasdaq: ANIX) is advancing a clinical-stage oncology pipeline focused on cancer vaccines and CAR-T therapy, led by its breast cancer vaccine program developed with Cleveland Clinic and supported by U.S. Department of Defense funding.In our exclusive interview, Dr. Amit Kumar,...
-
CEO Brandon Robinson on Horizon Aircraft’s (HOVR) Commercial eVTOL Advantages
In our exclusive interview, Brandon Robinson, Co-Founder, CEO, and Director of New Horizon Aircraft (Nasdaq: HOVR) breaks down why Horizon is taking a different path in advanced air mobility and why investors are starting to pay attention.Horizon’s Cavorite X7 is designed to combine vertical...
-
First Phosphate (FRSPF) CEO on $16.7M Non-Dilutive Funding, LFP Batteries, and Why FRSPF Stands Out
In our exclusive interview, John Passalacqua, CEO & Director of First Phosphate, explains why First Phosphate ($FRSPF | CSE: PHOS) is positioning itself as a critical North American supplier to the fast-growing LFP battery market.Key topics from the interview include:• A $16.7 million…
more -
RedChip Highlights Enlivex Therapeutics Ltd. (NASDAQ: ENLV) & Off The Hook Inc. (NYSE American: OTH)
This week's episode of Small Stocks Big Money features exclusive interviews with senior executives from Enlivex Therapeutics Ltd. (NASDAQ: ENLV) & Off The Hook Inc. (NYSE American: OTH)Explore the latest insights and updates in the world of small-cap stocks.Visit RedChip.com to learn more.
-
SCAP Portfolio Manager Jay Hatfield’s Market Playbook: Fed Cuts, Core PCE, and Small Caps
In our exclusive interview, Jay Hatfield (Founder, CEO, and Portfolio Manager at InfraCap) outlines a disciplined approach to small-cap investing built around profitability, valuation, and income generation and discusses the opportunity set for small caps as macro conditions evolve.Jay breaks…
more -
Enlivex (Nasdaq: ENLV) - FY25 Financial Results Webcast Replay
Watch our replay of Enlivex’s FY25 Financial Results Webcast to hear management discuss the company’s outlook, financial performance, and its differentiated dual strategy combining quality longevity therapeutics with a prediction markets treasury model.Key FY2025 Highlights:• Net income of $1.23...
-
Enlivex (ENLV) CEO: Two Pillars of Growth, Allocetra Knee OA Catalyst + RAIN Treasury Optionality
Enlivex (Nasdaq: ENLV) CEO Oren Hershkovitz breaks down the company’s two-pillar strategy designed to build shareholder value through both biotech execution and balance sheet strategy.Pillar 1: Clinical Development (AllocetraTM)Enlivex is advancing its immunotherapy platform with a focus on knee...
-
Off The Hook (NYSE American: OTH) CEO Interview: $145M Revenue Path, AI Boat Platform, Apex Upside
Off The Hook (NYSE American: OTH) CEO Brian John joins us for an exclusive interview to break down what makes OTH different from a traditional boat dealer and why management believes the company is entering a major growth phase.In our conversation, Brian explains how Off The Hook’s AI-powered...
-
Comprehensive Healthcare Systems (CMHSF | CHS): CEO Interview on Healthcare SaaS and Pipeline Growth
What makes Comprehensive Healthcare Systems (OTCQB: CMHSF | TSXV: CHS) a story investors should be watching right now?In our exclusive interview, Chris Cosgrove, President & CEO of Comprehensive Healthcare Systems, breaks down how the company is building a scalable healthcare SaaS platform…
more -
The Metals Company (TMC) CFO Craig Shesky: The NOAA Path, $23.6B NPV, and US Supply Security
@themetalscompany (Nasdaq: TMC) is a developer of lower-impact critical metals from seafloor polymetallic nodules, on a dual mission: (1) supply metals for energy, defense, manufacturing and infrastructure with net positive impacts compared to conventional production routes and (2) trace…
more -
BioVie (Nasdaq: BIVI) CEO Cuong Do on Near Term Catalysts in Parkinson’s, Long COVID, and Ascites
BioVie (Nasdaq: BIVI) President and CEO Cuong Do joins us for an exclusive investor interview discussing BioVie’s late-clinical-stage pipeline and upcoming milestones across neurodegeneration and liver disease.In our conversation, Cuong outlines why BioVie is targeting TNFα-mediated inflammation...
-
First Phosphate CEO John Passalacqua: Building a North American LFP Battery Supply Chain (FRSPF)
Lithium iron phosphate (LFP) batteries now power the majority of global battery production, but supply chains remain heavily concentrated in Asia. In our exclusive interview, First Phosphate (OTCQX: FRSPF | CSE: PHOS | FSE: KD0) CEO John Passalacqua explains how the company is working to onshore…
more -
Nexalin Technology (NXL) CEO Mark White: FDA Trials, At-Home Neurostimulation, and 2026 Milestones
In our investor-focused interview, Mark White, CEO of Nexalin Technology (Nasdaq: NXL), breaks down how the company is building a non-invasive neurostimulation platform aimed at major unmet needs across brain health, including depression, insomnia, PTSD/TBI, and Alzheimer’s/dementia.Nexalin’s...
-
OBOOK Holdings (OWLS) CEO Darren Wang on Regulated Stablecoin Payments, OwlPay Growth and 2026 Goals
Darren Wang, Founder, Chairman, and CEO of OBOOK Holdings (Nasdaq: OWLS), joins us to discuss how OwlTing is building a compliance-first stablecoin and fiat payment infrastructure for global commerce, as well as what investors should watch in 2026.In our interview, Darren explains why stablecoins...
-
NioCorp (NB) CEO Mark Smith on 2025 Milestones, Elk Creek Portal Buildout, and U.S. EXIM Financing
NioCorp (Nasdaq: NB) CEO Mark Smith joins us to break down a milestone year for the Elk Creek Critical Minerals Project in Nebraska and what could be next for U.S. onshoring of niobium, scandium, and magnetic rare earths.NioCorp is positioning Elk Creek as a construction-ready, fully permitted…
more -
ASP Isotopes (Nasdaq: ASPI) Investor Webinar - January 14, 2026
Join @RedChip for an investor Q&A webinar with ASP Isotopes (Nasdaq: ASPI) Executive Chairman and CEO Paul Mann, covering ASPI’s transition into commercial isotope production and its strategy at the intersection of clean energy, advanced semiconductors, and nuclear medicine.In our session, Paul...
-
Avalon Advanced Materials CEO Interview | $4B Lithium Opportunity + Rare Earth Supply Chain Upside
In our in-depth interview, Scott Monteith, CEO of Avalon Advanced Materials (OTCQB: AVLNF), breaks down why Avalon is emerging as one of North America’s most strategically positioned critical minerals companies.🔗 Avalon Advanced Materials is a client of RedChip. To learn more about AVLNF and to...
-
Alliance Entertainment (NASDAQ: AENT) Chairman on Earnings Growth and Exclusive IP Strategy
In this exclusive interview, Bruce Ogilvie, Executive Chairman of Alliance Entertainment (NASDAQ: AENT), outlines the company’s strategy to drive sustainable earnings growth across physical media, collectibles, and exclusive licensed content.Alliance Entertainment sits at the center of the global...
-
Processa Pharmaceuticals (PCSA) Interview: Phase 2 Breast Cancer Data, Pipeline Strategy & FDA Path
In this exclusive interview, David Young, PhD, President of Research & Development and Founder of Processa Pharmaceuticals (Nasdaq: PCSA), breaks down the latest Phase 2 clinical progress for the company’s lead oncology program targeting advanced breast cancer.🔬 Key Topics We Covered:• Positive...
-
New Era (Nasdaq: NUAI) CEO Discusses Power, AI Data Centers, and the Next Phase of Growth
In this exclusive interview, E. Will Gray II, Chairman, CEO, and Interim CFO of New Era Energy & Digital (Nasdaq: NUAI), breaks down the company’s strategy to become a critical player in AI data center infrastructure and power generation.New Era Energy & Digital is developing large scale, powered...
-
NioCorp CEO Mark Smith on U.S. Critical Minerals, Scandium Demand, and Project Financing Progress
In our in-depth interview, NioCorp (Nasdaq: NB) CEO Mark Smith discusses the rapidly evolving landscape for U.S. critical minerals and the company’s progress toward construction of its Elk Creek Project in Nebraska. Investors will gain insight into supply chain pressures, heavy rare earth export...
-
Nova Minerals CEO: $43.4M U.S. Funding Secured, Antimony Production by 2026 and 5.2Moz Gold Resource
📌 In our exclusive interview, Nova Minerals (Nasdaq: NVA) CEO Chris Gerteisen breaks down the company’s rapid transformation into a U.S. critical minerals and gold development leader. With a $43.4 million Defense Production Act award from the U.S. Department of War, Nova is advancing toward...
-
BullFrog AI CEO Vin Singh: Using AI to Transform Drug Discovery and Cut Development Costs
In this exclusive interview, BullFrog AI (Nasdaq: BFRG) CEO Vin Singh discusses how the company’s proprietary bfLEAP™ AI platform and BullFrog Data Networks™ are redefining the economics of drug discovery and development.💡 Key Highlights from the Interview:• Exclusive Data Access: Collaborations...
-
Jackpot Digital CEO Jake Kalpakian on Disrupting the Casino Industry with Dealerless Poker Tech
Jackpot Digital (OTCQB: JPOTF | TSXV: JJ) CEO Jake Kalpakian discusses how the company’s flagship Jackpot Blitz® platform is redefining casino poker economics through automation, recurring revenue, and global expansion.💡 Jackpot Digital represents an emerging opportunity at the intersection of...
-
Connect Biopharma CEO Barry Quart: Targeting a $5B+ Market with a Next-Gen Asthma & COPD Therapy
🚀 Connect Biopharma (Nasdaq: CNTB) is advancing rademikibart, a next-generation biologic designed to redefine how asthma and COPD are treated — tackling both chronic and acute exacerbations where no biologic currently competes.In this exclusive RedChip Money Report interview, CEO Dr. Barry Quart...
-
FatPipe Networks: CEO Dr. Ragula Bhaskar on Scaling Profitable Growth in SD-WAN and Cybersecurity
📊 FatPipe Networks (Nasdaq: FATN) — a pioneer in mission-critical networking and cybersecurity — is driving strong profitability and growth in the multi-billion-dollar SD-WAN and SASE markets.In this exclusive interview, Ragula Bhaskar, PhD, Co-Founder and CEO of FatPipe, discusses:✅ The…
more -
60 Degrees Pharmaceuticals: CEO Geoff Dow on Breakthrough Babesiosis Therapy & FDA Path Ahead
💡 60 Degrees Pharmaceuticals (Nasdaq: SXTP) CEO Geoff Dow discusses the company’s mission to tackle infectious diseases with unmet medical needs — and how its FDA-approved malaria drug ARAKODA® (tafenoquine) could soon transform treatment for babesiosis, a growing tick-borne disease with no...
-
Inside Bimergen Energy: $250M Equity Backing & 2GW BESS Pipeline with CFO Bob Brilon
🔋 Bimergen Energy (OTCQB: BESS) is emerging as a major player in the booming U.S. battery energy storage sector—and CFO Bob Brilon shares how the company is executing on a 2.0 GW pipeline backed by $250 million in equity commitments.With 2GW of BESS assets and a capital-efficient model designed…
more -
Inside Nexalin: Drug-Free Neuro Tech, Clinical Milestones, and What’s Next!
Mark White, CEO of Nexalin Technology (Nasdaq: NXL), joins us to discuss how Nexalin aims to simplify and make mental health care more accessible with its at-home “Halo” headset and a digital, physician-monitored model. We cover the latest peer-reviewed study results referenced by the company…
more -
Lantern Pharma CEO Panna Sharma Discusses Progress in AI-Driven Cancer Drug Development
Lantern Pharma Inc. (Nasdaq: LTRN) is a clinical-stage biopharmaceutical company redefiningoncology drug development through artificial intelligence. Its proprietary RADR® platform leveragesover 200 billion oncology-specific data points to rapidly identify drug candidates, optimize...
-
Foremost Clean Energy CEO on Nuclear's Resurgence & 330K Acre Uranium Portfolio
Foremost Clean Energy (Nasdaq: FMST) is a rapidly growing North American uranium exploration holding an option to earn up to a 70% interest in 10 underexplored properties from Denison Mines. The portfolio spans over 330,000 acres within a prospective area of the Athabasca Basin surrounded by...
-
PhoenixEV CEO John Walsh Interview: 2025 Goals, $200M Backlog and Transit Growth
Phoenix Motor (OTC: PEVMD) is a pioneer and emerging leader in the electric vehicle (“EV”) industry, designing, building, and integrating electric drive systems and manufacturing heavy-duty transit buses and medium- and light- duty commercial EVs. Phoenix operates two primary brands, PhoenixEV,...
-
Inside 60 Degrees Pharmaceuticals: CEO Geoffrey Dow on Revenue Growth & Pipeline Potential
60 Degrees Pharmaceuticals (Nasdaq: SXTP) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. 60P has successfully achieved...
-
Aptevo Therapeutics: Inside a Top-Tier Oncology Pipeline with COO Jeff Lamothe
Aptevo Therapeutics Inc. (Nasdaq: APVO) is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapies through its proprietary bispecific antibody platforms, ADAPTIR® and ADAPTIR-FLEX®. The company is advancing a diverse pipeline that includes both clinical and...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.
HOSTED BY
RedChip Companies
CATEGORIES
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Small Stocks, Big Money have?
Small Stocks, Big Money currently has 157 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Small Stocks, Big Money about?
RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals....
How often does Small Stocks, Big Money release new episodes?
Small Stocks, Big Money publishes regularly with 157 episodes available. Check the episode list for the typical release schedule.
Where can I listen to Small Stocks, Big Money?
You can listen to Small Stocks, Big Money on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Small Stocks, Big Money?
Small Stocks, Big Money is created and hosted by RedChip Companies.
URL copied to clipboard!